GeoVax Labs, Inc. GOVX 深 沪
已收盘 02-06 16:00:00 美东时间
2.67
+0.090
+3.49%
华盛通- 最 高2.715
- 今 开2.54
- 成交量 6.74万股
- 最 低 2.51
- 昨 收 2.58
- 总市值 462.48万
- 52周最高 47.125
- 市盈率 静 --
- 换手率 3.89%
- 52周最低 2.51
- 委 比 8.96%
- 总股本 173.21万
- 历史最高 3266.25
- 量 比 0.69
- 振 幅 7.95%
- 历史最低 2.51
- 每 手 1
- 风险率 10.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元
01-22 15:09
D. Boral Capital Maintains Buy on Geovax Labs, Maintains $6 Price Target
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintains $6 price target.
01-21 20:45
GeoVax Labs Announces 1-For-25 Reverse Stock Split, Effective January 9, 2026
On January 9, 2026, GeoVax Labs, Inc. (the "Company" or "we") filed a Certificate of Amendment to our Certificate of Incorporation effecting a 1-for-25 reverse stock split pursuant to which each twenty-five (25) shares
01-13 05:41
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 19.2% to $1...
01-09 20:05
GeoVax Labs Files Prospectus For Best-Efforts Offering Of 18,292,683 Units And Pre-Funded Units With Warrants
GEOVAX LABS, INC. 18,292,683 Common UnitsEach Common Unit Consisting ofOne Share of Common Stock andTwo Warrants to Purchase One Share of Common Stock 18,292,683 Pre-Funded UnitsEach Pre-Funded Unit
2025-12-13 06:42
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
2025-11-20 10:28
D. Boral Capital Maintains Buy on Geovax Labs, Lowers Price Target to $6
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and lowers the price target from $9 to $6.
2025-11-19 21:12
GeoVax outlines expedited GEO-MVA clinical trial and global partnership strategy for 2025-2026
Earnings Call Insights: GeoVax Labs (GOVX) Q3 2025 Management View David Dodd, Chairman, President & CEO, stated that "We remain confident in the continued progress and compelling outlook for our port...
2025-11-14 11:42
Geovax Labs Q3 EPS $(0.31) Misses $(0.25) Estimate
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.25) by 24 percent. This is a 65.93 percent increase over losses of $(0.91) per share from the
2025-11-14 05:07
美股大行评级 | 潜在涨幅485.44%！Allarity Therapeutics获机构升目标价至9.25美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9美元升至9.25美元；JMP证券：维持Crinetics Pharmaceuticals"跑赢大市"评级，目标价从86美元升至143美元
2025-09-29 09:15
